A cost-effectiveness analysis of axillary node dissection in postmenopausal women with estrogen receptor–positive breast cancer and clinically negative axillary nodes
✍ Scribed by Richard K. Orr; Nananda F. Col; Karen M. Kuntz
- Book ID
- 117221259
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 51 KB
- Volume
- 126
- Category
- Article
- ISSN
- 0039-6060
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Objectives: Sentinel lymph node biopsy (SLNB) is widely used for staging breast cancer. SLNB accurately determines axillary lymph node status with a low false negative rate. There remains concern that omitting axillary dissection may lead to recurrence in the axilla, and impact long term survival. T
## Abstract ## BACKGROUND: The regional lymph node control and survival impact of axillary dissection in breast cancer has been the subject of multiple randomized trials, with various results. This study reviews and conducts a meta‐analysis of contemporary trials of axillary dissection in patients